… According to rapid development of chemotherapy in advanced non-small cell lung cancer
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually since …

… Japanese Joint Committee of Lung Cancer Registry representing three major Japanese
societies that deal with patients with lung cancer… of the resected lung cancer were studied. Three …

… Conclusions: ILD was relatively common in these Japanese patients with NSCLC during
therapy with gefitinib or chemotherapy, being higher in the older, smoking patient with …

… of patients under 50 in the Japan Lung Cancer Registry Study (Sawabata, 2014), we investigated
the clinical features in patients under 50, in whom lung cancer … of these patients; with a …

… Immunological and nutritional markers could be useful for predicting the outcomes of CIT
for Japanese patients with advanced non‐small cell lung cancer. The timing of their evaluation …

… Cancer Center Hospital. Eighty-two of these patients had lung cancer, and all patients with
lung cancer … patients' charts and clinical records. At the time of data analysis, almost all of the …

… Patients One hundred and forty-one Japanese patients with untreated SCLC were diagnosed
between April 2006 and March 2011 at Kyoto University Hospital. Of these, 19 received …

… subgroup analysis of Japanese patients in the LUX-Lung 3 trial to confirm if the efficacy
and safety of afatinib in Japanese patients were consistent with the overall patient population. …

… general picture of medically treated lung cancer patients in Japan, including descriptive
statistics, treatment choice, and prognosis. About two-thirds of patients were classified as stage …

… not been investigated in Japanese patients with NSCLC. It is important that targeted agents
that are established in Western patients are also studied in Japanese patients, as ethnic …